A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Recruiting · NCT06630806 · Registry updated 2026-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma | Plasma Cell Myeloma Refractory | Recruiting | Phase 1 | 2026-03-25 | NCT06630806 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 | Hackensack | United States | 1 |
| Mayo Clinic in Arizona - Phoenix- Site Number : 8400005 | Phoenix | United States | 1 |
| Mayo Clinic in Florida- Site Number : 8400003 | Jacksonville | United States | 1 |
| Mayo Clinic in Rochester - Minnesota- Site Number : 8400004 | Rochester | United States | 1 |
| Thomas Jefferson University Hospital- Site Number : 8400002 | Philadelphia | United States | 1 |